How does the presence of ascites affect your treatment planning for SBRT for HCC?  

Given multidisciplinary discussion has occurred and SBRT has been agreed upon as local therapy, how do you approach the presence of moderate/significant ascites in regards to dose/fractionation and other planning considerations. 

Answer from: Radiation Oncologist at Academic Institution